Camenzind Samuel
Department of Philosophy, University of Vienna, Wien, Austria.
Xenotransplantation. 2024 Nov-Dec;31(6):e70008. doi: 10.1111/xen.70008.
The Federal Ethics Committee on Non-Human Biotechnology (ECNH) of Switzerland is an independent expert committee appointed by the Federal Council and mandated to advise the federal authorities from an ethical perspective in the field of nonhuman biotechnology and gene technology. Due to recent developments in the field of xenotransplantation after the introduction of genome editing technologies, the ECNH has commissioned an expert report on the ethical questions of xenotransplantation with a focus on animal ethics. The subject of the inquiry is, in particular, if current developments in the field of xenotransplantation raise new questions regarding ethics in the nonhuman realm or if existing questions have to be re-examined and answered anew.
An interdisciplinary approach was applied to answer this question. Based on the latest empirical results from medicine and biotechnology, xenotransplantation is analyzed and evaluated with reference to the dignity of the creature (Würde der Kreatur)-which is defined in the Swiss Federal Constitution-and the dignity of animals (Tierwürde) that is stipulated in the Swiss Animal Welfare Act and the Federal Act on Non-Human Gene Technology, as well as contemporary positions in the ethics of the human-animal relationship.
The report concludes that genome editing for xenotransplantation does not generate any qualitatively new ethical issues concerning ethics in the nonhuman realm. However, contemporary biotechnological developments must be taken as an opportunity to discuss existing ethical issues in an urgent and intensified manner, particularly regarding the significance of animals' moral standing. The lack of consideration of animal-related aspects and the neglect of current developments and the state of the art of animal ethics in the recent discussion about xenotransplantation is a scientific, ethical, and political issue because animals are most negatively affected by xenotransplantation. This is especially relevant because the contemporary state of the art in animal ethics tends to consider and protect animals more strongly than in the past.
瑞士联邦非人类生物技术伦理委员会(ECNH)是一个由联邦委员会任命的独立专家委员会,其职责是从伦理角度就非人类生物技术和基因技术领域向联邦当局提供建议。由于基因组编辑技术引入后异种移植领域的最新发展,ECNH委托撰写了一份关于异种移植伦理问题的专家报告,重点关注动物伦理。调查的主题尤其包括,异种移植领域当前的发展是否引发了关于非人类领域伦理的新问题,或者现有问题是否必须重新审视并给出新的答案。
采用跨学科方法来回答这个问题。根据医学和生物技术的最新实证结果,参照瑞士联邦宪法中定义的生物尊严(Würde der Kreatur)、瑞士动物福利法和联邦非人类基因技术法中规定的动物尊严(Tierwürde),以及人类与动物关系伦理中的当代观点,对异种移植进行分析和评估。
报告得出结论,用于异种移植的基因组编辑不会产生任何关于非人类领域伦理的质的新伦理问题。然而,当代生物技术的发展必须被视为一个契机,以紧迫和强化的方式讨论现有伦理问题,特别是关于动物道德地位的重要性。在最近关于异种移植的讨论中,缺乏对动物相关方面的考虑以及对动物伦理的当前发展和现状的忽视,是一个科学、伦理和政治问题,因为动物在异种移植中受到的负面影响最大。这一点尤为重要,因为当代动物伦理的现状往往比过去更加强调对动物的考虑和保护。